This inventor holds 1 USPTO granted patent. Top assignee: Institut Pasteur. Active years: 1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1989
Title: The Innovative Contributions of Philippe Quillardet
Introduction
Philippe Quillardet is a notable inventor based in Paris, France. He has made significant contributions to the field of biotechnology, particularly in the detection of mutagenic substances. His work is essential for understanding the effects of various substances on living organisms.
Latest Patents
Quillardet holds a patent for a method designed to detect the mutagenicity of substances. This innovative method involves producing a culture of a microorganism that harbors a recombinant sfi gene and a gene coding for a dosable enzyme. The process measures the activity of the dosable enzyme induced by the presence of a substance or composition. When the sfi gene is activated due to the mutagenic character of the substance, the activity of a distinct enzyme synthesized by the microorganism is measured. This allows for a comparison of the enzyme activities in the presence and absence of the mutagenic substance.
Career Highlights
Philippe Quillardet is affiliated with the prestigious Institut Pasteur, where he conducts his research. His work has garnered attention for its potential applications in safety testing and environmental monitoring. Quillardet's innovative approach to detecting mutagenicity is a testament to his expertise and dedication to advancing scientific knowledge.
Collaborations
Throughout his career, Quillardet has collaborated with esteemed colleagues such as Maurice Hofnung and David Perrin. These collaborations have further enriched his research and contributed to the development of new methodologies in the field.
Conclusion
Philippe Quillardet's contributions to the detection of mutagenic substances highlight his role as an influential inventor in the field of biotechnology. His innovative methods and collaborations continue to pave the way for advancements in safety and environmental health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
